SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia
Filed with ASX · · 2 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallMicroba Life Sciences Limited on 6ix
Earlier from Microba Life Sciences
- Microba Receives Ethics Approval for Phase 1 Clinical Trial
- SYNLAB Agreements Signed in Turkiye and Czech Republic
- Microba Launches Next Generation Healthcare Testing
- H1 FY23 Interim Report
- US Distribution Agreement Signed with Luminary Health
Later from Microba Life Sciences
- Q3 FY23 Quarterly Activities Report & Appendix 4C
- Q3 FY23 Quarterly Investor Presentation
- Microba receives two AusIndustry Advanced Overseas Findings
- MRFF Grant Awarded to QUT, In Collaboration With Microba
- Microba Commences Phase I Clinical Trial for IBD Therapeutic
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences